A MAajor RAdiation-based PCI Study in STEMI and NSTEMI

Launched by CENTRE CARDIOLOGIQUE DU NORD · Aug 21, 2024

Keywords

ClinConnect Summary

This clinical trial, called the MAJOR PCI Study, is investigating the effects of radiation and iodine used during a specific heart procedure known as percutaneous coronary angioplasty (PCI) in patients who have had a heart attack (either STEMI or NSTEMI). PCI is a procedure that helps open blocked arteries in the heart to improve blood flow. The study aims to understand more about the patients who undergo these complex procedures, how radiation and iodine affect them, and the risks involved, such as complications during and after the procedure.

To be eligible for this trial, patients must be between the ages of 65 and 87 and have experienced a STEMI or NSTEMI that requires either a simple or complex PCI. Participants can expect to be part of a study that aims to gather valuable information to improve future heart procedures and enhance patient safety. It’s important to note that the trial is not yet recruiting participants, so if you or a family member are interested, you might need to wait until it officially starts.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The patient presents with a STEMI or NSTEMI requiring either a non-complex or complex PCI.
• Exclusion Criteria:
• • -